Dublin, Ireland

Fournier Laboratories Ireland Limited

USPTO Granted Patents = 7

% Expired Patents = 14.3



Forward Citations = 77

Loading Chart...
Loading Chart...

11 inventors (with patents filed for the assignee):

goldMedal Tuula Ryde (4 out of 15 patents)

silverMedal Stephen B Ruddy (4 out of 31 patents)

bronzeMedal Rakesh A Patel (4 out of 8 patents)

4.  Rajeev A Jain (4 out of 13 patents)

5.  Evan E Gustow (4 out of 7 patents)

6.  Michael John Wilkins (4 out of 4 patents)

7.  Eric Bruckert (1 out of 1 patent)

8.  Philippe Dellis (1 out of 2 patents)

9.  Kamel Nasar (1 out of 1 patent)

10.  Gerald Francis Watts (1 out of 1 patent)

11.  David Alan Playford (1 out of 1 patent)

12.  Jean-Louis Junien (33 patents)

13.  Evelyne Chaput (2 patents)

14.  Rajeev Jain (0 patent)

15.  Michael John Wilkins (0 patent)


7 patents:

Company Overview
Fournier Laboratories Ireland Limited is a leading pharmaceutical company specializing in the development and manufacturing of innovative medical solutions. With a strong focus on research and development, Fournier Laboratories is committed to improving healthcare outcomes for patients worldwide. The company offers a wide range of high-quality products in various therapeutic areas, including cardiology, neurology, and oncology.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

7 Patents

#137 in Dublin

#252 in Ireland

Dublin, IE
Dublin, Ireland
Forward Citations = 77

11 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Fournier Laboratories Ireland Limited. Retrieved from https://idiyas.com/company/fournier-laboratories-ireland

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…